Customize your JAMA Network experience by selecting one or more topics from the list below.
In the article titled “Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial,”1 published online September 5, 2019, the wrong initial was used for Dr Harding’s middle name. Dr Harding’s correct name is James J. Harding, MD. This article has been corrected online.
Error in Author’s Name. JAMA Oncol. 2019;5(11):1643. doi:10.1001/jamaoncol.2019.4781
Coronavirus Resource Center